Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System

被引:61
|
作者
Gombash, Sara E. [1 ,2 ]
Manfredsson, Fredric P. [2 ]
Kemp, Christopher J. [2 ]
Kuhn, Nathan C. [2 ]
Fleming, Sheila M. [3 ,4 ]
Egan, Ann E. [1 ]
Grant, Laura M. [5 ,6 ]
Ciucci, Michelle R. [5 ,6 ]
MacKeigan, Jeffrey P. [7 ]
Sortwell, Caryl E. [2 ]
机构
[1] Univ Cincinnati, Grad Program Neurosci, Cincinnati, OH USA
[2] Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI USA
[3] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA
[4] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA
[5] Univ Wisconsin, Dept Surg, Madison, WI USA
[6] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA
[7] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA
来源
PLOS ONE | 2013年 / 8卷 / 11期
关键词
PARKINSONS-DISEASE; ULTRASONIC VOCALIZATIONS; DOPAMINE TRANSPORTER; LEWY BODIES; MODEL; NEURONS; SENSORIMOTOR; NEURODEGENERATION; PHOSPHORYLATION; NEUROPROTECTION;
D O I
10.1371/journal.pone.0081426
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The discovery of the involvement of alpha-synuclein (alpha-syn) in Parkinson's disease (PD) pathogenesis has resulted in the development and use of viral vector-mediated alpha-syn overexpression rodent models. The goal of these series of experiments was to characterize the neurodegeneration and functional deficits resulting from injection of recombinant adeno-associated virus (rAAV) serotype 2/5-expressing human wildtype alpha-syn in the rat substantia nigra (SN). Rats were unilaterally injected into two sites in the SN with either rAAV2/5-expressing green fluorescent protein (GFP, 1.2 x 10(13)) or varying titers (2.2 x 10(12), 1.0 x 10(13), 5.9 x 10(13), or 1.0 x 10(14)) of rAAV2/5-alpha-syn. Cohorts of rats were euthanized 4, 8, or 12 weeks following vector injection. The severity of tyrosine hydroxylase immunoreactive (THir) neuron death in the SN pars compacta (SNpc) was dependent on vector titer. An identical magnitude of nigrostriatal degeneration (60-70% SNpc THir neuron degeneration and 40-50% loss of striatal TH expression) was observed four weeks following 1.0 x 1014 titer rAAV2/5-alpha-syn injection and 8 weeks following 1.0 x 1013 titer rAAV2/5-alpha-syn injection. THir neuron degeneration was relatively uniform throughout the rostral-caudal axis of the SNpc. Despite equivalent nigrostriatal degeneration between the 1.0 x 10(13) and 1.0 x 10(14) rAAV2/5-alpha-syn groups, functional impairment in the cylinder test and the adjusting steps task was only observed in rats with the longer 8 week duration of alpha-syn expression. Motor impairment in the cylinder task was highly correlated to striatal TH loss. Further, 8 weeks following 5.9 x 10(13) rAAV2/5-alpha-syn injection deficits in ultrasonic vocalizations were observed. In conclusion, our rAAV2/5-alpha-syn overexpression model demonstrates robust nigrostriatal alpha-syn overexpression, induces significant nigrostriatal degeneration that is both vector and duration dependent and under specific parameters can result in motor impairment that directly relates to the level of striatal TH denervation.
引用
收藏
页数:15
相关论文
共 12 条
  • [1] Overexpression of Non-Aggregatable Alpha-Synuclein Protects Against Human Wildtype Alpha-Synuclein Mediated Toxicity
    Kanaan, Nicholas M.
    Kuhn, Nathan C.
    Sortwell, Caryl S.
    Jiang, Chuantao
    Manfredsson, Fredric P.
    MOLECULAR THERAPY, 2012, 20 : S32 - S32
  • [2] Alpha-Synuclein Overexpression in the Aged Rat Brain: Is the Aging Nigrostriatal System More Suseptible to α-Synuclein Mediated Neurodegeneration?
    Gombash, S. E.
    Manfredsson, F. P.
    Kemp, C. J.
    Wohlgenant, S. L.
    Fischer, D. L.
    Daley, B. F.
    Collier, T. J.
    Lipton, J. W.
    Cole-Strauss, A.
    Mandel, R. J.
    Fleming, S. M.
    Sortwell, C. E.
    MOLECULAR THERAPY, 2012, 20 : S67 - S67
  • [3] AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson’s disease
    Friederike Freiin von Hövel
    Regina Rumpel
    Andreas Ratzka
    Dietmar Schreiner
    Claudia Grothe
    Cell and Tissue Research, 2019, 378 : 1 - 14
  • [4] AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease
    von Hoevel, Friederike Freiin
    Rumpel, Regina
    Ratzka, Andreas
    Schreiner, Dietmar
    Grothe, Claudia
    CELL AND TISSUE RESEARCH, 2019, 378 (01) : 1 - 14
  • [5] rAAV2/5-Mediated Gene Transfer Is Less Efficient in the Aged Rat Brain: Examination of α-Synuclein-Mediated Neurodegeneration in the Nigrostriatal System
    Manfredsson, F. P.
    Gombash, S. E.
    Kemp, C. J.
    Fischer, D. L.
    Kuhn, N. C.
    Cole-Strauss, A.
    Mandel, R. J.
    Fleming, S. M.
    Collier, T. J.
    Lipton, J. W.
    Sortwell, C. E.
    CELL TRANSPLANTATION, 2013, 22 (05) : 909 - 909
  • [6] rAAV2/5-Mediated Gene Transfer Is Less Efficient in the Aged Rat Brain: Examination of α-Synuclein-Mediated Neurodegeneration in the Nigrostriatal System
    Gombash, Sara E.
    Manfredsson, Fredric P.
    Kemp, Christopher H.
    Fischer, David L.
    Kuhn, Nathan C.
    Cole-Strauss, Allyson
    Mandel, Ronald J.
    Fleminig, Sheila M.
    Collier, Timothy J.
    Lipton, Jack W.
    Sortwell, Caryl E.
    MOLECULAR THERAPY, 2013, 21 : S148 - S149
  • [7] Modelling Non-motor Symptoms of Parkinson's Disease: AAV Mediated Overexpression of Alpha-synuclein in Rat Hippocampus and Basal Ganglia
    Mutluay, Sevgi Ugur
    Cinar, Elif
    Cakmakli, Gul Yalcin
    Ulusoy, Ayse
    Elibol, Bulent
    Tel, Banu Cahide
    TURKISH JOURNAL OF NEUROLOGY, 2020, 26 (04) : 322 - 329
  • [8] A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration
    Polissidis, Alexia
    Koronaiou, Effrosyni
    Nikolopoulou, Georgia
    Viel, Catherine
    Nikatou, Maria
    Bogiongko, Marios
    Sardi, S. Pablo
    Xilouri, Maria
    Vekrellis, Kostas
    Stefanis, Leonidas
    NEUROBIOLOGY OF DISEASE, 2022, 163
  • [9] AAV2 - mediated delivery of human neurturin to the rat nigrostriatal system: Long-term efficacy and tolerability of CERE-120 for Parkinson's disease
    Gasmi, Mehdi
    Brandon, Eugene P.
    Herzoga, Christopher D.
    Wilson, Alistair
    Bishop, Kathie M.
    Hofer, Eva K.
    Cunningham, Justine J.
    Printz, Marie A.
    Kordower, Jeffrey H.
    Bartus, Raymond T.
    NEUROBIOLOGY OF DISEASE, 2007, 27 (01) : 67 - 76
  • [10] Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy
    Lin, Darshong
    Donsante, Anthony
    Macauley, Shannon
    Levy, Beth
    Vogler, Carole
    Sands, Mark S.
    MOLECULAR THERAPY, 2007, 15 (01) : 44 - 52